A Phase I Trial of Escalating Dose of RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Everolimus (Primary) ; Midostaurin
- Indications Acute myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 07 Jul 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 07 Jul 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated